Renalytix plc Stock Price, News & Analysis
Company Description
Renalytix plc (NASDAQ: RNLX) is a publicly traded diagnostic imaging centers company in the Services-medical Laboratories sector. The company has a market capitalization of $17.2M, ranking #6,347 among all listed U.S. companies by market cap.
RNLX stock has declined 82.5% over the past year. Shares last traded at $0.2071.
This page provides a comprehensive overview of RNLX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Renalytix plc (RNLX) stock last traded at $0.2071. Over the past 12 months, the stock has lost 82.5%. At a market capitalization of $17.2M, RNLX is classified as a micro-cap stock with approximately 165.9M shares outstanding.
RNLX Rankings
Latest News
Renalytix plc has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences. View all RNLX news →
SEC Filings
Renalytix plc has filed 3 recent SEC filings, including 2 Form S-8 POS, 1 Form 15-12G. The most recent filing was submitted on July 30, 2025. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all RNLX SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
RNLX Company Profile & Sector Positioning
Renalytix plc (RNLX) operates in the Diagnostic Imaging Centers industry within the broader Services-medical Laboratories sector and is listed on the NASDAQ.